EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!

Anchorperson: F. Mahfoud
Moderator: L. Lauder
SHOW MORE

Summary

Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.

Learning Objectives

  • To appreciate the impact of hypertension
  • To discuss established and novel treatment option for hypertension
  • To learn more about recent clinical data on renal denervation

Presentations available when logged in:

  • Session objectives
  • Renal denervation increases time in target range: SPYRAL-HTN ON MED 3 year data
  • Patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio
  • Blood pressure and MACE reductions after renal denervation: 3-year GSR results